Clinical Study Confirms Lubrizol MAGSHAPE™ Enhances Magnesium Absorption

Clinical Study Confirms Lubrizol MAGSHAPE™ Enhances Magnesium Absorption Lubrizol’s MAGSHAPE™ microcapsules, a micronized and microencapsulated form of magnesium, have been found to significantly improve magnesium absorption compared to other commonly used magnesium sources, according to a recent study published in…

Read MoreClinical Study Confirms Lubrizol MAGSHAPE™ Enhances Magnesium Absorption
Legends

Dignity Health Enhances Community Ties with Bakersfield Arena and Venue Partnership

Dignity Health Enhances Community Ties with Bakersfield Arena and Venue Partnership The City of Bakersfield, California, has partnered with Dignity Health to expand their naming-rights agreement for one of the region’s key venues. The downtown complex, formerly known as Centennial…

Read MoreDignity Health Enhances Community Ties with Bakersfield Arena and Venue Partnership

Study Confirms Lubrizol’s MAGSHAPE™ Enhances Magnesium Absorption

Study Confirms Lubrizol’s MAGSHAPE™ Enhances Magnesium Absorption Lubrizol’s MAGSHAPE™ microcapsules, a micronized and microencapsulated form of magnesium, have been shown in a recent study to significantly enhance magnesium absorption compared to other widely used magnesium sources. The clinical study, published…

Read MoreStudy Confirms Lubrizol’s MAGSHAPE™ Enhances Magnesium Absorption

NaphCare Chosen by New Mexico Corrections for Electronic Health Record Technology

NaphCare Chosen by New Mexico Corrections for Electronic Health Record Technology NaphCare, Inc., a leading provider of correctional healthcare solutions, is excited to announce the successful implementation of its TechCare electronic health record (EHR) system for the New Mexico Corrections…

Read MoreNaphCare Chosen by New Mexico Corrections for Electronic Health Record Technology

Futibatinib Now Available in Italy for Cholangiocarcinoma Treatment, Announces Taiho Oncology Europe

Futibatinib Now Available in Italy for Cholangiocarcinoma Treatment, Announces Taiho Oncology Europe Taiho Oncology Europe GmbH has announced the availability of futibatinib in Italy for the treatment of cholangiocarcinoma (CCA), a rare and aggressive bile duct cancer. This follows the…

Read MoreFutibatinib Now Available in Italy for Cholangiocarcinoma Treatment, Announces Taiho Oncology Europe

Access Vascular Catheters with MIMIX® Tech Added to Recon Supply’s Federal Contract

Access Vascular Catheters with MIMIX® Tech Added to Recon Supply’s Federal Contract Access Vascular, Inc. (AVI), a leader in addressing critical vascular access challenges through its innovative hydrophilic biomaterial technology, has announced that its range of vascular access catheters featuring…

Read MoreAccess Vascular Catheters with MIMIX® Tech Added to Recon Supply’s Federal Contract

eXciteOSA® Daytime Sleep Apnea Therapy Now Covered by Georgia Medicaid

eXciteOSA® Daytime Sleep Apnea Therapy Now Covered by Georgia Medicaid Signifier Medical Technologies Limited (“Signifier”), a global leader in sleep-disordered breathing treatments, announced today that its non-invasive daytime therapy, eXciteOSA®, is now covered under Georgia Medicaid policy 1320. This development…

Read MoreeXciteOSA® Daytime Sleep Apnea Therapy Now Covered by Georgia Medicaid

Seaport Therapeutics Publishes Research on 55% Drug Absorption via Lymphatics with Glyph™ Platform

Seaport Therapeutics Publishes Research on 55% Drug Absorption via Lymphatics with Glyph™ Platform Seaport Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative neuropsychiatric medicines, has announced the publication of new research highlighting the unique capabilities of its Glyph™ platform…

Read MoreSeaport Therapeutics Publishes Research on 55% Drug Absorption via Lymphatics with Glyph™ Platform